X Bioscience PCL (BKK:XBIO)

X Bioscience PCL Revenue

X Bioscience PCL had revenue of 82.97M THB in the quarter ending March 31, 2026, with 55.56% growth. This brings the company's revenue in the last twelve months to 159.29M, down -46.33% year-over-year. In the year 2025, X Bioscience PCL had annual revenue of 129.65M, down -59.39%.

• Revenue (ttm): 159.29M
• Revenue Growth: -46.33%
• P/S Ratio: 6.10
• Revenue / Employee: 399.22K
• Employees: 399
• Market Cap: 972.08M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	129.65M	-189.59M	-59.39%
Dec 31, 2024	319.24M	7.47M	2.40%
Dec 31, 2023	311.77M	-32.71M	-9.50%
Dec 31, 2022	344.49M	90.44M	35.60%
Dec 31, 2021	254.04M	-161.57M	-38.88%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 25, 2026

Data Sources Report a data error